A roadmap of priority evidence gaps for the co-implementation of malaria vaccines and perennial malaria chemoprevention
Grant J. et al, (2025), Malaria Journal, 24
Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses.
Huang CQ. et al, (2025), Emerg Microbes Infect, 14
Developing the next-generation of adenoviral vector vaccines.
Sampson AT. et al, (2025), Human vaccines & immunotherapeutics, 21
Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.
Kantor J. et al, (2025), Hum Vaccin Immunother, 21
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis
Li X. et al, (2025), BMC Medicine, 23
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants
Guo L. et al, (2025), Nature Communications, 16
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development
Siegal EZ. et al, (2025), npj Vaccines, 10
Repertoire, function, and structure of serological antibodies induced by the R21/Matrix-M malaria vaccine.
McDaniel JR. et al, (2025), J Exp Med, 222
Targeting MHC-E as a new strategy for vaccines and immunotherapeutics
BORROW P. et al, (2025), Nature Reviews Immunology
Evaluation of 1st WHO anti-malaria reference reagent for competition ELISA harmonisation and development of ADAMSEL analytical platform.
Khatri B. et al, (2025), Biologicals
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil
Costa Clemens SA. et al, (2025), Mayo Clinic Proceedings Innovations Quality and Outcomes, 9
A vaccine emergency – when to overrule parental refusal of vaccination at birth for prevention of vertical transmission of hepatitis B virus?
Wilkinson D. and SAVULESCU J., (2025), Archives of Disease in Childhood
Rabies glycoprotein engineering for improved stability and expression.
English S. et al, (2025), Vaccine, 62
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.
McLean RK. et al, (2025), NPJ Vaccines, 10
Salmonella Typhi gut invasion drives hypoxic immune subsets associated with disease outcomes
Bossel Ben-Moshe N. et al, (2025), Nature Communications, 16, 6755 - 6755
MetE: a promising protective antigen for tuberculosis vaccine development
Almujri SS. et al, (2025), Frontiers in Immunology, 16
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).
Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
O'Connor D. et al, (2025), Nat Commun, 16